Related Blog Entries

• Patient sues Medtronic over painful lead shocks
• Unsealed Lipitor lawsuit alleges defective marketing
• Family hits GlaxoSmithKline with Avandia wrongful death lawsuit
• JAMA study also says Avandia causes heart attack
• Texas Vioxx Jurors did not accept Merck’s arguments
• First federal Vioxx trial scheduled
• Celebrex label revised yet again
• Judge rules health plans can sue over Vioxx prescription costs
• Texas sues Merck over Vioxx
• Medtronic did not fix defibrillator flaws
• Merck sought combo drug to lessen Vioxx risk
• Merck pressured doctors to refrain from discussing Vioxx safety concerns
• Guidant hid Ventak Prizm 2 flaw
• Cleveland Clinic suggests ban on Natrecor
• Zyprexa, Seroquel linked to rise in elderly deaths
• Natrecor safety study still not underway
• Natrecor Safety Study announced
• Link between Natrecor and early deaths
• Natrecor worsens kidney risk
• Avandia carries black box warning of risk of heart attack, chest pain
• Merck allots $4.85 billion to settle Vioxx lawsuits
• Study linking Vioxx to heart problems finally published
• Welch Allyn recalls external defibrillators because of failures, delays in devices
• FDA receives more testimony against Trasylol
• Report Shows Avandia and Actos Increase Heart Failure Risk
• Questions and Answers about diabetes drug Avandia
• Professor testifies GSK trials of Avandia about marketing, not safety
• Patients start to file cases against Avandia
• Congressmen concerned about Avandia risks
• FDA wants ‘black box’ warning on Avandia
• FDA reprimands its own scientist for Avandia warning
• FDA adds black box warning to Avandia, diabetes drugs